<DOC>
	<DOCNO>NCT00683176</DOCNO>
	<brief_summary>The purpose study evaluate effect choline fenofibrate regression macular edema eye subject type 2 diabetes mellitus ( T2DM ) present diabetic macular edema ( DME )</brief_summary>
	<brief_title>Effect Choline Fenofibrate ( SLV348 ) Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Inclusion Criteria With DME least one eye subject eye present macula thickness ≥ 300 µm OCT examination baseline least one 5 follow zone : center zone , superior inner zone , nasal inner zone , inferior inner zone , temporal inner zone , confirmed central reading OCT ; When laser treatment safely postpone least 3 month ; With establish T2DM HbA1c &lt; 10 % ; With systolic blood pressure ( SBP ) diastolic blood pressure ( DBP ) &lt; 160/90 mmHg ; With document elevated triglyceride level ( TG &gt; =150 mg/dL [ 1.70 mmol/L ] ) screen visit previous 3 month . Exclusion Criteria Previous laser photocoagulation ; Eye retinal thickening result epiretinal membrane vitreomacular traction ; glaucoma ; Poor visual acuity : visual acuity 20/800</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>OCT</keyword>
</DOC>